Predictive Oncology Inc (POAI)

[Cphelan23]

We have positioned Helomics to compete in the marketplace,” he said. “The original basis of Helomics… was that physicians or hospitals would send their tumors to this company and they would test the tumors with the known therapies of the day… In that process, [Helomics] accumulated over 150,000 tumors covering over 137 different cancers… That database is the largest of its kind in the world… With that data, and the fact that we’ve sequenced these tumors, we have shown that we can provide quality information to anyone who needs it. There’s a lot going on at Helomics. We think we’ve validated the company. We’ve got assets that are one-of-a-kind in the world, and we think we are on our way to where we wanted to be when we first purchased this company a couple of years ago.”

Please listen to the full interview with Predictive Oncology CEO Carl Schwartz at https://nnw.fm/e0fDA.